+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Zygomatic and Pterygoid Implants - Global Market Trajectory & Analytics

  • ID: 5140736
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Implance
  • Jeil Medical Corporation
  • S.I.N. IMPLANT
  • Silimed
  • Southern Implants
  • Straumann
Global Zygomatic and Pterygoid Implants Market to Reach $338.9 Million by 2027

Amid the COVID-19 crisis, the global market for Zygomatic and Pterygoid Implants estimated at US$249 Million in the year 2020, is projected to reach a revised size of US$338.9 Million by 2027, growing at a CAGR of 4.5% over the analysis period 2020-2027. Severe Atrophy of Maxillary Bone, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$158.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Maxillary sinuses segment is readjusted to a revised 4.3% CAGR for the next 7-year period.





The U.S. Market is Estimated at $73.3 Million, While China is Forecast to Grow at 4.2% CAGR

The Zygomatic and Pterygoid Implants market in the U.S. is estimated at US$73.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$59.8 Million by the year 2027 trailing a CAGR of 4.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 3.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Other Applications Segment to Record 3.6% CAGR

In the global Other Applications segment, USA, Canada, Japan, China and Europe will drive the 3.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$41.5 Million in the year 2020 will reach a projected size of US$53.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$38.8 Million by the year 2027.

Select Competitors (Total 44 Featured):
  • Implance
  • Jeil Medical Corporation
  • S.I.N. IMPLANT
  • Silimed
  • Southern Implants
  • Straumann
  • Titaniumfix
Frequently Asked Questions about the Global Market for Zygomatic and Pterygoid Implants

What is the estimated value of the Global Market for Zygomatic and Pterygoid Implants?

The Global Market for Zygomatic and Pterygoid Implants was estimated to be valued at $249.0 Million in 2020.

What is the growth rate of the Global Market for Zygomatic and Pterygoid Implants?

The growth rate of the Global Market for Zygomatic and Pterygoid Implants is 4.5%, with an estimated value of $338.9 Million by 2027.

What is the forecasted size of the Global Market for Zygomatic and Pterygoid Implants?

The Global Market for Zygomatic and Pterygoid Implants is estimated to be worth $338.9 Million by 2027.

Who are the key companies in the Global Market for Zygomatic and Pterygoid Implants?

Key companies in the Global Market for Zygomatic and Pterygoid Implants include Implance, Jeil Medical Corporation, S.I.N. IMPLANT, Silimed, Southern Implants and Titaniumfix.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Implance
  • Jeil Medical Corporation
  • S.I.N. IMPLANT
  • Silimed
  • Southern Implants
  • Straumann

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Zygomatic and Pterygoid Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Zygomatic and Pterygoid Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Zygomatic and Pterygoid Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Severe Atrophy of Maxillary Bone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Severe Atrophy of Maxillary Bone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Severe Atrophy of Maxillary Bone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for Maxillary sinuses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Maxillary sinuses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Maxillary sinuses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 10: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS
  • UNITED STATES
  • Table 13: USA Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 14: USA Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: USA 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027
  • CANADA
  • Table 16: Canada Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 17: Canada Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: Canada 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027
  • JAPAN
  • Table 19: Japan Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 20: Japan Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: Japan 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027
  • CHINA
  • Table 22: China Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 23: China Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: China 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027
  • EUROPE
  • Table 25: Europe Current & Future Analysis for Zygomatic and Pterygoid Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 26: Europe Historic Review for Zygomatic and Pterygoid Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 27: Europe 15-Year Perspective for Zygomatic and Pterygoid Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 28: Europe Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 29: Europe Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 30: Europe 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027
  • FRANCE
  • Table 31: France Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: France Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 33: France 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027
  • GERMANY
  • Table 34: Germany Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 35: Germany Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 36: Germany 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027
  • ITALY
  • Table 37: Italy Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: Italy Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 39: Italy 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
  • Table 40: UK Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 41: UK Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 42: UK 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027
  • REST OF EUROPE
  • Table 43: Rest of Europe Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: Rest of Europe Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 45: Rest of Europe 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
  • Table 46: Asia-Pacific Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 47: Asia-Pacific Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 48: Asia-Pacific 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027
  • REST OF WORLD
  • Table 49: Rest of World Current & Future Analysis for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Rest of World Historic Review for Zygomatic and Pterygoid Implants by Application - Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 51: Rest of World 15-Year Perspective for Zygomatic and Pterygoid Implants by Application - Percentage Breakdown of Value Sales for Severe Atrophy of Maxillary Bone, Maxillary sinuses and Other Applications for the Years 2012, 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Implance
  • Jeil Medical Corporation
  • S.I.N. IMPLANT
  • Silimed
  • Southern Implants
  • Straumann
  • Titaniumfix
Note: Product cover images may vary from those shown